Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01237353 · ClinicalTrials.gov registry record · NA
Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers
A NA study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT01237353: Completed NA study, sponsored by University of California, San Francisco.
NCT01237353 is a NA study that has completed, run by University of California, San Francisco. The registered enrollment target is 6 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01237353, a NA study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
In this study the investigators will test a nutritional supplement called betaine hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers who have decreased stomach acid because they take a medicine called rabeprazole.
Primary Outcome
Gastric pH levels monitored with a Heidelberg pH capsule (HC) which sends real-time signals to a computer system that visually plots intestinal pH on a minute-by-minute basis. When subject's pH remained above 4.0 for at least 15 minutes, a 1500 mg dose of betaine HCl was given orally with 90 mL of water, and gastric pH was continuously monitored for 2 hours.
Interventions
- DRUG Rabeprazole
- DIETARY_SUPPLEMENT betaine hydrochloride
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2011-03 |
| Est. Completion | 2011-07 |
| Phase | NA |
What the finished NCT01237353 record still lists
NCT01237353 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 2 interventions - of which Rabeprazole is the first listed.
NCT01237353 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01237353 about?
NCT01237353 is a clinical study titled "Study of the Ability of Betaine Hydrochloride to Increase Stomach Acid in Healthy Volunteers". In this study the investigators will test a nutritional supplement called betaine hydrochloride to see if it can temporarily increase the stomach acid in healthy volunteers who have decreased stomach acid because they take a medicine called rabeprazole.
What is the current status of trial NCT01237353?
This trial is currently completed. It is a NA study. The enrollment target is 6 participants. The study started on 2011-03. Estimated completion is 2011-07.
What interventions are being tested in trial NCT01237353?
The interventions under investigation include: Rabeprazole (DRUG), betaine hydrochloride (DIETARY_SUPPLEMENT).
Who is sponsoring clinical trial NCT01237353?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01237353's enrollment target sits among peer trials
6 1983rd of 2000 higher than 13 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia